Funding for this research was provided by:
stichting de weijerhorst (Weij1031)
fonds onderzoek en innovatie mmc (2020.COI.018)
Received: 29 July 2021
Accepted: 10 November 2021
First Online: 25 November 2021
: This study protocol and execution of the study will be fully compliant to the most recently updated version of the Declaration of Helsinki. The researchers will protect confidential data conform the rules and regulations stated in the Dutch General Data Protection Regulation. The method for data storage and handling is approved by the data security officer of Máxima MC. The Medical Ethics Committee of Máxima MC extensively reviewed the study protocol and concluded that the study is in line with the Medical Research Involving Human Subjects Act. Therefore, ethical approval was granted (W20.076 / NL73607.015.20). Máxima MC Board of Management also approved the conduct of this study at their hospital. Written informed consent will be obtained from all subjects involved in the study.
: Not applicable.
: SO initiated the scientific research from which Nemo Healthcare and the described NFMS device have originated. There are no financial relationships between Nemo Healthcare and any of the authors.